CENB.F Stock Overview
Focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CEN Biotech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.018 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | -99.00% |
| 3 Month Change | 0% |
| 1 Year Change | -99.98% |
| 33 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CENB.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | -100.0% | 14.2% | 32.3% |
Return vs Industry: CENB.F underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.
Return vs Market: CENB.F underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| CENB.F volatility | |
|---|---|
| CENB.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CENB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CENB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Brian Payne | www.cenbiotechinc.com |
CEN Biotech, Inc. focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products. It intends to cultivate hemp for usage in industrial, medical, and food products; and to provide digital marketing and web design related services. The company was incorporated in 2013 and is based in Windsor, Canada.
CEN Biotech, Inc. Fundamentals Summary
| CENB.F fundamental statistics | |
|---|---|
| Market cap | US$65.00 |
| Earnings (TTM) | -US$3.10m |
| Revenue (TTM) | US$1.03m |
0.0x
P/S Ratio0.0x
P/E RatioIs CENB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CENB.F income statement (TTM) | |
|---|---|
| Revenue | US$1.03m |
| Cost of Revenue | US$0 |
| Gross Profit | US$1.03m |
| Other Expenses | US$4.13m |
| Earnings | -US$3.10m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CENB.F perform over the long term?
See historical performance and comparison